Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Padcev Extends Survival in Bladder Cancer, Trial Stopped Early: Astellas/Seattle Genetics
Astellas Pharma/Seattle Genetics’ antibody-drug conjugate (ADC) Padcev (enfortumab vedotin) hit the primary endpoint of overall survival (OS) in a PIII bladder cancer trial, EV-301, with the study stopped early thanks to positive interim analysis data. In the EV-301 study, Padcev…
To read the full story
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





